glp-1 and alcohol use GLP‐1 Receptor Agonists for Treating Disorder: A Critical Review - Woo - 2026 - Alcohol, Clinical Experimental Research Effects of glucagon-like peptide-1 (GLP-1)

Pharmacol Res 1(130):164171 Matuskova Z, Anzenbacherova E, Vecera R, Tlaskalova-Hogenova H, Kolar M, Anzenbacher P (2014) Administration of a probiotic can change drug pharmacokinetics: effect of E

A study of retatrutide in participants with obesity and cardiovascular disease began enrolment for Phase III clinical trials in 2023

Association of hypoglycemia with subsequent dementia in older patients with type 2 diabetes mellitus

Introduction The coronavirus disease 2019 (COVID-19) pandemic affected more than 602.8 million cases with more than 6.4 million deaths reported globally (The New York Times, 2022)

Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by Mod GRF 1-29, a long-acting GH-releasing hormone analog

Currently, no GLP-1s for the indication of weight loss have successfully completed this national review process, the statement reads